FdaApplication
ANDA 091544
Identifiers
- fda_app_no: ANDA091544
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK PHARMACEUTICALS INC USA |
| application_type | ANDA |
| approval_date | 2010-12-27 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LITHIUM CARBONATE | LITHIUM CARBONATE | 300MG | TABLET, EXTENDED RELEASE;ORAL |
1 product